Kazia Therapeutics Ltd Stock Price Patterns
| KZIA Stock | USD 5.13 0.13 2.47% |
Momentum 41
Sell Extended
Oversold | Overbought |
EPS Estimate Current Year (0.01) | EPS Estimate Next Year (0.01) | Wall Street Target Price 19.4144 | Quarterly Revenue Growth (0.27) |
Using Kazia Therapeutics hype-based prediction, you can estimate the value of Kazia Therapeutics Ltd from the perspective of Kazia Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Kazia Therapeutics using Kazia Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Kazia using crowd psychology based on the activity and movement of Kazia Therapeutics' stock price.
Kazia Therapeutics Implied Volatility | 2.61 |
Kazia Therapeutics' implied volatility exposes the market's sentiment of Kazia Therapeutics Ltd stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Kazia Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Kazia Therapeutics stock will not fluctuate a lot when Kazia Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Kazia Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Kazia because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Kazia Therapeutics after-hype prediction price | USD 5.64 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Kazia Therapeutics Basic Forecasting Models to cross-verify your projections. Kazia Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Kazia Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kazia Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Kazia Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kazia Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Kazia Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kazia Therapeutics' historical news coverage. Kazia Therapeutics' after-hype downside and upside margins for the prediction period are 0.28 and 18.36, respectively. We have considered Kazia Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kazia Therapeutics is risky at this time. Analysis and calculation of next after-hype price of Kazia Therapeutics is based on 3 months time horizon.
Kazia Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Kazia Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kazia Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kazia Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.40 | 12.62 | 0.34 | 0.01 | 9 Events / Month | 5 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
5.13 | 5.64 | 7.22 |
|
Kazia Therapeutics Hype Timeline
Kazia Therapeutics is now traded for 5.13. The entity has historical hype elasticity of 0.34, and average elasticity to hype of competition of -0.01. Kazia is forecasted to increase in value after the next headline, with the price projected to jump to 5.64 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 7.22%, whereas the daily expected return is now at 0.4%. The volatility of related hype on Kazia Therapeutics is about 60095.24%, with the expected price after the next announcement by competition of 5.12. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out Kazia Therapeutics Basic Forecasting Models to cross-verify your projections.Kazia Therapeutics Related Hype Analysis
Having access to credible news sources related to Kazia Therapeutics' direct competition is more important than ever and may enhance your ability to predict Kazia Therapeutics' future price movements. Getting to know how Kazia Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kazia Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CANF | Can Fite Biopharma | (0.20) | 8 per month | 0.00 | (0.11) | 10.40 | (8.59) | 38.42 | |
| CNSP | CNS Pharmaceuticals | 0.16 | 6 per month | 0.00 | (0.18) | 7.22 | (8.99) | 31.54 | |
| SILO | Silo Pharma | 0.00 | 0 per month | 0.00 | (0.15) | 8.33 | (10.00) | 24.79 | |
| SNGX | Soligenix | (0.17) | 8 per month | 0.00 | (0.05) | 8.16 | (6.25) | 30.10 | |
| BDRX | Biodexa Pharmaceticals | (0.25) | 8 per month | 0.00 | (0.06) | 11.45 | (16.09) | 128.35 | |
| CMND | Clearmind Medicine Common | (0.19) | 10 per month | 0.00 | (0.40) | 11.60 | (21.84) | 56.34 | |
| INM | InMed Pharmaceuticals | (0.03) | 8 per month | 0.00 | (0.13) | 7.48 | (9.30) | 30.84 | |
| GRI | GRI Bio | 0.28 | 7 per month | 0.00 | (0.33) | 11.88 | (20.75) | 77.14 | |
| OGEN | Oragenics | 0.00 | 8 per month | 0.00 | (0.17) | 7.32 | (8.33) | 24.70 | |
| TTNP | Titan Pharmaceuticals | 0.19 | 2 per month | 5.38 | 0.03 | 9.38 | (8.08) | 30.41 |
Kazia Therapeutics Additional Predictive Modules
Most predictive techniques to examine Kazia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kazia using various technical indicators. When you analyze Kazia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Kazia Therapeutics Predictive Indicators
The successful prediction of Kazia Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kazia Therapeutics Ltd, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kazia Therapeutics based on analysis of Kazia Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kazia Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kazia Therapeutics's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 1.32 | 0.36 | 0.42 | 0.39 | Revenue Per Share | 4.81 | 0.0383 | 0.0441 | 0.0419 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Kazia Stock analysis
When running Kazia Therapeutics' price analysis, check to measure Kazia Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kazia Therapeutics is operating at the current time. Most of Kazia Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kazia Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kazia Therapeutics' price. Additionally, you may evaluate how the addition of Kazia Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |